Drug intelligence / Profile preview

steviol glycoside

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Steviol glycosides are natural, high-intensity, zero-calorie sweeteners extracted from the leaves of the *Stevia rebaudiana* plant. Chemically, they are diterpene glycosides sharing a common steviol aglycone backbone with varying sugar moieties, with stevioside and rebaudioside A being the most abundant. Steviol glycosides primarily act by binding and activating the sweet taste receptor heterodimer TAS1R2/TAS1R3 on taste bud cells to convey sweet taste perception. Beyond their use as sugar substitutes, steviol glycosides have been investigated for potential therapeutic benefits in metabolic disorders, including type 2 diabetes, obesity, and hypertension. These effects are partially mediated through the potentiation of the calcium-activated cation channel TRPM5, which stimulates insulin secretion from pancreatic beta-cells, as well as the modulation of glucose absorption and insulin sensitivity.

Brand names
SugarO LiteSugarO StrongZerocal SteviaZerova
Other names
ent-kaurene glycosidesrebaudioside Arebaudioside Drebaudioside Mstevia extractstevia leaf extractsteviol glycosidesstevioside
02

Targets

TAS1R2 (Taste receptor type 1 member 2)TAS1R3 (Sweet taste receptor T1R3 subunit)TRP (TRP channels)

Beyond the preview

Go deeper on steviol glycoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on steviol glycoside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call